Cerebral Assessment Systems Announces US Launch of the World’s 1st FDA Cleared Automated Cognition Assessment Solution
It’s been over a year since Cerebral Assessment Systems (CAS) received FDA-approval for their computerized cognitive testing solution, Cognivue. Recently, CAS has announced the US commercial launch of Cognivue and a partnership with National MedSales Associates, a company that organizes independent sales teams, to distribute the device nationally. Ben Winton, the VP and Managing Partner at MedSales, says: “We look for practice-changing products like Cognivue that will enable better patient care and outcomes and help reduce costs.”
CAS has additionally signed agreements with two national organizations. TechTrans will package, ship, and install the Cognivue units, and Maxim Staffing Solutions will provide personnel to set-up the software and train the customer on Cognivue use. Partnering with these companies will expand CAS’s market reach nationwide. “By collaborating with MedSales and our distribution partners, we are able to address the needs of the underserved cognitive health market place,” said Steve Otis, Vice President of Sales at CAS.